183 related articles for article (PubMed ID: 11263500)
1. Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas.
Leuraud P; Marie Y; Robin E; Huguet S; He J; Mokhtari K; Cornu P; Hoang-Xuan K; Sanson M
J Neurooncol; 2000 Dec; 50(3):207-13. PubMed ID: 11263500
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of alterations of the p18INK4c gene in human meningiomas.
Santarius T; Kirsch M; Nikas DC; Imitola J; Black PM
Neuropathol Appl Neurobiol; 2000 Feb; 26(1):67-75. PubMed ID: 10736068
[TBL] [Abstract][Full Text] [Related]
4. Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors.
Husemann K; Wolter M; Büschges R; Boström J; Sabel M; Reifenberger G
J Neuropathol Exp Neurol; 1999 Oct; 58(10):1041-50. PubMed ID: 10515227
[TBL] [Abstract][Full Text] [Related]
5. GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis.
Piaskowski S; Rieske P; Szybka M; Wozniak K; Bednarek A; Płuciennik E; Jaskolski D; Sikorska B; Liberski PP
Cancer Genet Cytogenet; 2005 Oct; 162(1):63-7. PubMed ID: 16157202
[TBL] [Abstract][Full Text] [Related]
6. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
Sulman EP; Dumanski JP; White PS; Zhao H; Maris JM; Mathiesen T; Bruder C; Cnaan A; Brodeur GM
Cancer Res; 1998 Aug; 58(15):3226-30. PubMed ID: 9699646
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.
Tahara H; Smith AP; Gaz RD; Zariwala M; Xiong Y; Arnold A
J Bone Miner Res; 1997 Sep; 12(9):1330-4. PubMed ID: 9286748
[TBL] [Abstract][Full Text] [Related]
8. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
[TBL] [Abstract][Full Text] [Related]
9. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the p15, p16,and p18 genes in osteosarcoma.
Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
[TBL] [Abstract][Full Text] [Related]
11. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
12. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
[TBL] [Abstract][Full Text] [Related]
13. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
Nunes F; Shen Y; Niida Y; Beauchamp R; Stemmer-Rachamimov AO; Ramesh V; Gusella J; MacCollin M
Cancer Genet Cytogenet; 2005 Oct; 162(2):135-9. PubMed ID: 16213361
[TBL] [Abstract][Full Text] [Related]
14. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
15. P18 tumor suppressor gene and progression of oligodendrogliomas to anaplasia.
He J; Hoang-Xuan K; Marie Y; Leuraud P; Mokhtari K; Kujas M; Delattre JY; Sanson M
Neurology; 2000 Sep; 55(6):867-9. PubMed ID: 10994011
[TBL] [Abstract][Full Text] [Related]
16. Deletion mapping of the long arm of chromosome 22 in human meningiomas.
Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I
Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
18. Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32.
Mendiola M; Bello MJ; Alonso J; Leone PE; Vaquero J; Sarasa JL; Kusak ME; De Campos JM; Pestaña A; Rey JA
Mol Carcinog; 1999 Apr; 24(4):300-4. PubMed ID: 10326867
[TBL] [Abstract][Full Text] [Related]
19. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
20. Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas.
Boström J; Mühlbauer A; Reifenberger G
Acta Neuropathol; 1997 Nov; 94(5):479-85. PubMed ID: 9386781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
